Papers/PMID:27759579
Oral magnesium supplementation improves endothelial function and attenuates subclinical atherosclerosis in thiazide-treated hypertensive women.
Journal of hypertension2017The record
1 finding · 1 compound · 1 endpoint
What it reported
How to read these marksWhat moved
1 finding
magnesium(2+) — increases flow-mediated dilation
Evidence strength: very limited.Findingreplicated ×1“The magnesium group demonstrated a significant increase in variation of FMD vs. the placebo group (+3.7 ± 2.1 vs. 2.4 ± 1.2%, P = 0.015).”
Quoted verbatim from Oral magnesium supplementation improves endothelial function and attenuates subclinical atherosclerosis in thiazide-treated hypertensive women.. - Study
- RCT
- Duration
- 6 months
- Dose
- magnesium chelate 600 mg/day
- Population
- Hypertensive women aged 40-65 years on hydrochlorothiazide with mean 24-h BP of at least 130/80 mmHg, both arms thiazide-treated; 6-month follow-up
Oral magnesium supplementation improves endothelial function and attenuates subclinical atherosclerosis in thiazide-treated hypertensive women.2017PMID:2775957910.1097/HJH.0000000000001129Permalink